Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02494817 · ClinicalTrials.gov registry record · NA
HIV Prevention Toolkit for HIV-negative Male Couples
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 298
- Enrollment target
NCT02494817 is a NA study that has completed, run by University of Miami. The registered enrollment target is 298 participants.
The verdict
NCT02494817, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
Study Summary
Though technology is integrated into the lives of our target population, use of any particular technology will depend on the content delivered, aesthetic appeal, and overall design. Based on the completion and analysis of data from Phase 1, the investigators were able to obtain feedback on HIV-negative male couples' attitudes toward the original content in the prevention toolkit modules. The research team, along with the web-developers, used this feedback to specifically tailor the content of the modules to fit the unique needs of the intervention's target population: at risk HIV-negative male couples. For Phase 2, the investigators conducted focus groups at each site to help identify strengths and potential areas for improvement of the prevention toolkit, which will be incorporated before piloting it in the intervention for Phase 3 of this project. After assessing the acceptability of the prevention toolkit, including the content of modules, aesthetic appeal, and overall design with HIV-negative male couples target population, the research team will pilot test whether the RCT with the prevention toolkit will help reduce HIV risk through formation and adherence to a sexual agreement, reduction in occurrences of condomless anal sex with casual sex partners, and increase testing behaviors among at-risk HIV-negative male couples. The interactive website, herein referred to as the "HIV prevention toolkit" will contain unique modules about sexual agreements and effective HIV prevention strategies.
Interventions
- BEHAVIORAL Male Couples Agreement Project
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02494817
The ClinicalTrials.gov registry entry for NCT02494817 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Male Couples Agreement Project is the first listed.
NCT02494817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02494817 about?
NCT02494817 is a clinical study titled "HIV Prevention Toolkit for HIV-negative Male Couples". Though technology is integrated into the lives of our target population, use of any particular technology will depend on the content delivered, aesthetic appeal, and overall design. Based on the completion and analysis of data from Phase 1, the investigators were able to obtain feedback on HIV-negat...
What is the current status of trial NCT02494817?
This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2015-10. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02494817?
The interventions under investigation include: Male Couples Agreement Project (BEHAVIORAL).
Who is sponsoring clinical trial NCT02494817?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.